About
Centese develops the Thoraguard system, an FDA-cleared digital surgical drainage device for cardiothoracic surgery that provides automated clog clearance and real-time monitoring of air leaks and drainage volume to support clinical decision-making and improve patient outcomes.
Explore Centese's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.